QA: Nexien Biopharma INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001625288_2024_Nexien_Biopharma_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001625288, Nexien Biopharma INC

  xvar xval
0 AssetsCurrent 43,127
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 295,134
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 190,368
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 36,066
11 remainder_Revenues 0
12 remainder_NetIncome -85,590
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 43,127
1 Liabilities 295,134
2 Expenses 226,434
3 Revenues 0
4 StockholdersEquity -252,007
5 NetIncome -312,024
6 ComprehensiveNetIncome -312,024
7 BaseVar 325,142
8 EconomicCapitalRatiobeforeLimitedLiability -5.09
9 EconomicCapitalRatio 0.177

Edgar->Model Mapping

Feature Distribution

Change over Time